Friday broker round-up
5th Oct 2018 13:40
(Sharecast News) - Intertek Group: Berenberg upgrades to buy with a target price of 5,500p.
Read moreIntertek offers strong structural growth through the cycle - Berenberg
5th Oct 2018 12:41
(Sharecast News) - Intertek's share price woes are overdone, believes Berenberg, upgrading the product testing, inspection and certification specialist to 'buy' from 'hold'.
Read moreWednesday broker round-up
19th Sep 2018 13:13
(Sharecast News) - PureCircle: Kepler Cheuvreux downgrades to hold with a target price of 325p.
Read moreIntertek replaces finance chief Ed Leigh in management shakeup
22nd Aug 2018 07:06
(Sharecast News) - Intertek has replaced chief financial officer Ed Leigh with group financial controller Ross McCluskey in a management shakeup at the product testing company.
Read moreThursday broker round-up
9th Aug 2018 13:02
(Sharecast News) - BBA Aviation: Liberum upgrades to buy with a target price of 370p.
Read moreWednesday broker round-up
8th Aug 2018 12:36
(Sharecast News) - Spire Healthcare Group: Berenberg downgrades to sell with a target price of 120p.
Read moreIntertek profit rises, interim dividend lifted as product division does well
7th Aug 2018 07:37
(Sharecast News) - Product testing company Intertek posted a rise in first half-profit on Tuesday thanks to a strong performance from its products division, as it hiked its dividend.
Read moreUK equities look overbought, says Credit Suisse
6th Aug 2018 13:46
(Sharecast News) - Since April, UK equities have outperformed euro area stocks by around 3% and global stocks by around 1%, but with oil prices felt to have peaked and shares looking "overbought", Credit Suisse strategists have downgraded their stance.
Read moreIntertek buys US-based Alchemy for $480m
3rd Aug 2018 07:06
(Sharecast News) - Product testing company Intertek on Friday said it was buying US-based software provider Alchemy for $480m (£368.8m) in cash.
Read moreCredit Suisse downgrades Intertek to 'underperform'
17th Jan 2017 08:36
(ShareCast News) - Credit Suisse has downgraded Intertek to 'underperform' from 'neutral' and cut the price target to 3,200p from 3,400p as it took a more cautious view on the rate of recovery in the resources operations and increased risk to its consumer and product divisions. The bank said it ex
Read moreWednesday broker round-up
23rd Nov 2016 14:29
(ShareCast News) - Anglo American: UBS reiterates neutral with a target price of 950p. Lloyds: Macquarie reiterates outperform with a 65p target. Intertek: Barclays stays at equal-weight with a 3700p target. Barclays: HSBC reiterates buy with a 190p target. Homeserve: UBS maintains neutral with a
Read moreIntertek's revenues grow but resources continues to weigh
22nd Nov 2016 07:08
(ShareCast News) - While conditions for its resources division continue to remain challenging, Intertek drove revenues higher in the third quarter to remain on track to deliver full year growth and cash generation. For the 10 months ended 31 October, revenue grew 18% to £2.09bn compared to the same
Read moreIntertek creates water testing joint venture in Mexico
15th Nov 2016 07:07
(ShareCast News) - Assurance provider Intertek has partnered with ABC Analitic, a water test provider, to form an environmental services joint venture in Mexico. The FTSE 100 company, which will own the majority of the joint venture, will use it become a market leader in assurance, testing, inspecti
Read moreWednesday broker round-up
26th Oct 2016 17:40
(ShareCast News) - FirstGroup: Goldman Sachs keeps at buy with a target price of 168p. Esure: Berenberg stays at sell, 238p target. Anglo American: Deutsche Bank reiterates hold with a 965p target. Intertek: UBS reiterates buy with a 4100p target. Sainsbury: Goldman Sachs reiterates sell with a 1
Read moreRBC Capital shifts ratings on business services sector stocks
13th Oct 2016 12:48
(ShareCast News) - RBC Capital Markets initiated coverage of several stocks and changed its recommendations as it took a look at the business services sector. The bank started Ashtead at 'outperform' with a 1,580p price target, saying it sees a robust US market, while the branch rollout and discipli
Read more